Drug firms found liable in Vegas hepatitis C case
Hospital Safety Connection, October 13, 2011
Want to receive articles like this one in your inbox? Subscribe to Hospital Safety Connection!
Drug companies must pay a total of $20.1 million to five plaintiffs affected by an outbreak of hepatitis C in 2008 at Las Vegas endoscopy and colonoscopy clinics.
Teva Parenteral Medicines, Inc., Baxter Healthcare Corp., and McKesson Corp. were held liable for injuries and accused of neglecting patient safety by distributing vials that were much larger than needed to the clinics. Reuse of vials makes it possible to transfer bloodborne pathogens to patients.
Want to receive articles like this one in your inbox? Subscribe to Hospital Safety Connection!
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- Q&A: Coding for dry skin due to cold weather
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- Catch up on what's new with injections and infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- Q&A: Coding for sepsis when other conditions are present
- Are your workforce members texting PHI?
- HIPAA Q&A: TPO disclosures to a business associate
- Q&A: Coding for dry skin due to cold weather
- What does case-mix index mean to you?
- First board certification for hospitalists announced -- with caution
- Searched
